A Recombinant Bispecific CD20 x CD95 Antibody With Superior Activity Against Normal and Malignant B-cells

Nalivaiko, Kristina; Hofmann, Martin; Kober, Karina; Teichweyde, Nadine; Krammer, Peter H.; Rammensee, Hans-Georg; Grosse-Hovest, Ludger; Jung, Gundram

dc.contributor.author	Nalivaiko, Kristina
dc.contributor.author	Hofmann, Martin Florian
dc.contributor.author	Kober, Karina
dc.contributor.author	Teichweyde, Nadine
dc.contributor.author	Rammensee, Hans-Georg
dc.contributor.author	Große-Hovest, Ludger
dc.contributor.author	Jung, Gundram
dc.date.accessioned	2017-03-15T14:36:57Z
dc.date.available	2017-03-15T14:36:57Z
dc.date.issued	2016
dc.identifier.issn	1525-0024
dc.identifier.uri	http://hdl.handle.net/10900/75044
dc.language.iso	en	en
dc.publisher	Nature Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/mt.2015.209
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	A Recombinant Bispecific CD20 x CD95 Antibody With Superior Activity Against Normal and Malignant B-cells	de_DE
dc.type	Article	de_DE
utue.quellen.id	20160915142648_01778
utue.publikation.seiten	298-305	de_DE
utue.personen.roh	Nalivaiko, Kristina
utue.personen.roh	Hofmann, Martin
utue.personen.roh	Kober, Karina
utue.personen.roh	Teichweyde, Nadine
utue.personen.roh	Krammer, Peter H.
utue.personen.roh	Rammensee, Hans-Georg
utue.personen.roh	Grosse-Hovest, Ludger
utue.personen.roh	Jung, Gundram
dcterms.isPartOf.ZSTitelID	Molecular Therapy	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	24	de_DE
utue.fakultaet	04 Medizinische Fakultät